Blood-testing startup Theranos is said to be shutting down

 The once-heralded blood-testing startup Theranos is shutting down, according to a new report.

Theranos was unable to sell itself and is now looking to pay unsecured creditors its remaining cash of about $5 million in the upcoming months, according to an email The Wall Street Journal obtained that CEO David Taylor sent to shareholders.